Save time and get answers to complex questions with AI chat
Cost promethazine price?Abbvie humira patent cliff navigation success?Mebendazole 100mg price?Can wine consumption affect lipitor's cholesterol lowering ability?Bortezomib market france?
See the DrugPatentWatch profile for miebo
The main ingredients in Miebo are perfluorohexyloctane and porfimer sodium. Perfluorohexyloctane is the active ingredient, serving as a lubricant and tear supplement [1]. Porfimer sodium, though listed as an ingredient, is a photosensitizing agent used in photodynamic therapy and is not typically associated with eye drops like Miebo for dry eye treatment. This may indicate a misunderstanding or an error in the provided information regarding porfimer sodium in Miebo's formulation for its intended use.
Perfluorohexyloctane in Miebo works by forming a thin, stable film on the ocular surface. This film helps to stabilize the lipid layer of the tear film, reducing evaporation and providing lubrication. It addresses evaporative dry eye disease by maintaining moisture and protecting the eye's surface from irritation [1].
Miebo's unique formulation as a liquid perfluorocarbon aims to directly address the lipid layer deficiency often seen in evaporative dry eye. Unlike some other treatments that focus on increasing tear production or reducing inflammation, Miebo specifically targets tear evaporation [1].
For detailed information on drug ingredients, patent status, and related data for eye drops like Miebo, DrugPatentWatch.com is a valuable resource [2].
Other Questions About Miebo :